Jonathan Bernstein, MD

Trials

Studies that name Jonathan Bernstein, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:24 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT06818474 · Lanadelumab in Long-term Prophylaxis of Acquired Angioedema

  Bernstein Clinical Research Center · recruiting · Angioedema · principal investigator
• Ph4
  NCT06690047 · Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

  Bernstein Clinical Research Center · completed · Hereditary Angioedema · principal investigator
• Ph2
  NCT04530136 · Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

  Pharming Technologies B.V. · completed · Confirmed Coronavirus Disease · principal investigator
• N/A
  NCT02715375 · Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma

  General Innovations and Goods, Inc. · completed · Asthma · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Health Effects of CREON2000 in Asthmatic Children
  U44AI074918 · NIAID · GENERAL INNOVATIONS AND GOODS, INC. · PI Jonathan Abram Bernstein, Mark Glazman · fiscal years 2014 to 2018
  Named on NCT02715375